Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery

European Heart Journal

Volumn 26, Issue 22, 2005, Pages 2440-2447

  Thielmann, Matthias ^a   Massoudy, Parwis ^a   Schmermund, Axel ^a   Neuhäuser, Markus ^a   Marggraf, Günter ^a   Kamler, Markus ^a   Herold, Ulf ^a   Aleksic, Ivan ^a   Mann, Klaus ^a   Haude, Michael ^a   Heusch, Gerd ^a   Erbel, Raimund ^a   Jakob, Heinz ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Bypass graft failure; Coronary artery disease; Myocardial infarction; Surgery

Indexed keywords

CREATINE KINASE; TROPONIN I;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; HEART INFARCTION; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; GRAFT REJECTION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE CARE; RETREATMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 27644569169     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi437     Document Type: Article

References (35)

1. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Effects of acadesine on the incidence of myocardial infarction and adverse cardiac outcomes after coronary artery bypass graft surgery. Anesthesiology 1995;83:658-673.
2. Mangano DT, Layug EL, Wallace A, Tateo I, the Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713-1721.
3. Mangano DT, the Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002;347:1309-1317.
4. Jain U. Myocardial infarction during coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1992;6:612-623.
5. Force T, Hibberd P, Weeks G, Kemper AJ, Bloomfeld P, Tow D, Josa M, Khuri S, Parisi AF. Perioperative myocardial infarction after coronary artery bypass surgery: clinical significance and approach to risk stratification. Circulation 1990;82:903-912.
6. Rasmussen C, Thiis JJ, Clemmensen P, Efsen F, Arendrup HC, Saunamäki K, Madsen JK, Pettersson G. Significance and management of early graft failure after coronary artery bypass grafting: feasibility and results of acute angiography and re-vascularisation. Eur J Cardiothorac Surg 1997;12:847-852.
7. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
8. Califf RM, Abdelmeguid AE, Kuntz RE, Pompa JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman EM. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998;31:241-251.
9. Carrier M, Pellerin M, Perrault LP, Solymoss BC, Pelletier LC. Troponin I levels in patients with myocardial infarction after coronary artery bypass grafting. Ann Thorac Surg 2000;69:435-440.
10. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: should the paradigm be expanded? Circulation 1989;79:441-444.
11. Holmvang L, Jurlander B, Rasmussen C, Thiis JJ, Grande P, Clemmensen P. Use of biochemical markers of infarction for diagnosing perioperative myocardial infarction and early graft occlusion after coronary artery bypass surgery. Chest 2002;121:103-111.
12. Kim CB, Braunwald E. Potentail benefits of late reperfusion of infarcted myocardium: the open artery hyopthesis. Circulation 1993;88:2426-2436.
13. Adams JE III, Bodor GS, Dávila-Román VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 1993;88;101-106.
14. Jacquet L, Noirhomme P, El Khoury G, Goenen M, Philippe M, Col J, Dion R. Cardiac troponin I as an early marker of myocardial damage after coronary artery bypass surgery. Eur J Cardiothorac Surg 1998;13:378-384.
15. Newman MF. Troponin I in cardiac surgery: marking the future. Am Heart J 2001;141:325-326.
16. Thielmann M, Massoudy P, Marggraf G, Knipp S, Schmermund A, Piotrowski J, Erbel R, Jakob H. Role of troponin I, myoglobin, and creatine kinase for the detection of early graft failure following coronary artery bypass grafting. Eur J Cardiothorac Surg 2004;26:102-109.
17. Adams JE III, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Dávila-Román VG, Bodor GS, Ladenson JH, Jaffe AS. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 1994;330:670-674.
18. Bonnefoy E, Filley S, Kirkorian G, Guidollet J, Roriz R, Robin J, Touboul P. Troponin I, troponin T, or creatine kinase-MB to detect perioperative myocardial damage after coronary artery bypass surgery. Chest 1998;114:482-486.
19. Haude M, Baumgart D, Verna E, Piek JJ, Vrints C, Probst P, Erbel R. Intracoronary doppler- and quantitative coronary angiography-derived predictors of major adverse cardiac events after stent implantation. Circulation 2001;103:1212-1217.
20. Erbel R, Heusch G. Brief review: coronary microembolization. J Am Coll Cardiol 2000;36:22-24.
21. Thielmann M, Dorge H, Martin C, Belosjorow S, Schwanke U, van de Sand A, Konietzka I, Buchert A, Kruger A, Schulz R, Heusch G. Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine. Circ Res 2002;19:807-813.
22. Fransen EJ, Diris JHC, Maessen JG, Hermens WTh, van Dieijen-Visser MP. Evaluation of 'new' cardiac markers for ruling out myocardial infarction after coronary artery bypass grafting. Chest 2002;122:1316-1321.
23. Jain U, Laflamme CAJ, Aggarwal A, Ramsay JG, Comunale ME, Ghoshal S, Ngo L, Ziola K, Hollenberg M, Mangano DT. Electrocardiographic and hemodynamic changes and their association with myocardial infarction during coronary artery bypass surgery. A multicenter study. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Anesthesiology 1997;86:576-591.
24. Comunale ME, Body SC, Ley C, Koch C, Roach G, Mathew JP, Herskowitz A, Mangano DT. The concordance of intraoperative left ventricular wall-motion abnormalities and electrocardiographic ST-segment changes: association with outcome after coronary revascularization. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Anesthesiology 1998;88:945-954.
25. Sadony V, Körber M, Albes G, Podtschaske V, Etgen T, Trösken T, Ravens U, Scheulen ME. Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 1998;13:57-65.
26. Steuer J, Bjerner T, Duvernoy O, Jideus L, Johansson L, Ahlstrom H, Stahle E, Lindahl B. Visualisation and quantification of perioperative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging. Eur Heart J 2004;25:1293-1299.
27. Herrmann J, Haude M, Lerman A, Schulz R, Volbracht L, Ge J, Schmermund A, Wieneke H, von Birgelen C, Eggebrecht H, Baumgart D, Heusch G, Erbel R. Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation. Circulation 2001;103:2339-2345.
28. Heusch G, Schulz R, Haude M, Erbel R. Coronary microembolization. J Mol Cell Cardiol 2004;37:23-31.
29. Heusch G, Schulz R. Pathophysiology of coronary microembolisation. Heart 2003;89:981-982.
30. Skyschally A, Haude M, Dorge H, Thielmann M, Duschin A, van de Sand A, Konietzka I, Buchert A, Aker S, Massoudy P, Schulz R, Erbel R, Heusch G. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization. Circulation 2004;109:2337-2342.
31. Petzold T, Feindt P, Sunderdiek U, Boeken U, Fischer Y, Gams E. Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. Eur J Cardiothorac Surg 2001;19:859-864.
32. Hasegawa T, Yoshimura N, Oka S, Ootaki Y, Toyoda Y, Yamaguchi M. Evaluation of heart fatty acid-binding protein as a rapid indicator for assessment of myocardial damage in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2004;127:1697-1702.
33. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001;141:985-991.
34. Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, Honda SA, Rios CN, Sugiyama CE, Ha CE. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003;49:581-585.
35. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003;107:2403-2405.